Fox Chase Cancer Center News

PHILADELPHIA (April 15, 2024) — Physicians at Fox Chase Cancer Center have now treated 1,000 patients using the EnVisio real-time Surgical Navigation System and SmartClip Tumor Marker since Fox Chase became the first cancer center in the Northeast to implement the technology in 2020.

PHILADELPHIA (April 15, 2024) — With potential implications for quality-of-care and access to services, Medicare reimbursement for most common breast cancer surgeries declined significantly over the last 20 years when adjusted for inflation, according to a new study presented at the American Society of Breast Surgeons (ASBS) Annual Meeting.

PHILADELPHIA (April 10, 2024) — In a study published today in the prestigious journal Nature, researchers from Fox Chase Cancer Center have shown that a newly developed compound was able to block necroptosis, a type of cell death that leads to lung inflammation and damage following infection with the influenza virus.

PHILADELPHIA (April 10, 2024) — Camille Ragin, PhD, MPH, Associate Director for Diversity, Equity, and Inclusion at Fox Chase Cancer Center, received the American Association for Cancer Research’s (AACR) Minorities in Cancer Research Jane Cooke Wright Lectureship. She delivered the lecture at the AACR Annual Meeting 2024 being held in San Diego.

PHILADELPHIA (April 8, 2024) — In a study presented today at the American Association for Cancer Research (AACR) Annual Meeting 2024, researchers at Fox Chase Cancer Center showed that estrogen is metabolized extensively in both mouse and human lungs, ultimately contributing to the development of lung cancer in people who have never smoked. Investigators at Fox Chase are the first to report this finding.

PHILADELPHIA (April 8, 2024) — In a study presented today at the American Association for Cancer Research (AACR) Annual Meeting 2024, researchers at Fox Chase Cancer Center showed that in mice with a BAP1 germline mutation, even minimal exposure to chrysotile asbestos significantly increases susceptibility to the development of malignant mesothelioma. The study is being posted simultaneously online in Cancer Research Communications, a journal of the AACR.

PHILADELPHIA (April 5, 2024)—Fox Chase Cancer Center and the Lewis Katz School of Medicine at Temple University researchers will participate in the presentation and discussion of 16 research projects at the American Association of Cancer Research (AACR) Annual Meeting 2024, which is being held in San Diego April 5-10. An asterisk (*) indicates that the author is the main presenter.